Interactions of cytosolic sulfotransferases with xenobiotics

Drug Metabolism Reviews

Volumn 45, Issue 4, 2013, Pages 401-414

  James, Margaret O ^a   Ambadapadi, Sriram ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Dietary sulfotransferase inhibitors; Enhancement of sulfonation; Inhibition of sulfotransferases

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; CELECOXIB; FLAVONOID; ISOENZYME; KYNURENIC ACID; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1A3; SULFOTRANSFERASE 1B1; SULFOTRANSFERASE 1E1; SULFOTRANSFERASE 2A1; TRANSFERASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADRENAL GLAND; BRAIN; CATALYSIS; CYTOSOL; HUMAN; INTESTINE; LIVER; MOLECULAR INTERACTION; PROTEIN FUNCTION; REVIEW; SKIN; SULFONATION;

ANIMALS; CYTOSOL; GENE EXPRESSION; HUMANS; ISOENZYMES; METABOLIC DETOXICATION, DRUG; ORGAN SPECIFICITY; SUBSTRATE SPECIFICITY; SULFOTRANSFERASES; XENOBIOTICS;

EID: 84887361225     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2013.835613     Document Type: Review

References (117)

1. Al-Dujaili EA, Kenyon CJ, Nicol MR, Mason JI. (2011). Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity. Mol Cell Endocrinol 336:102-109.
2. Allmyr M, Adolfsson-Erici M, Mclachlan MS, Sandborgh-Englund G. (2006). Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 372: 87-93. (Pubitemid 44751071)
3. Allmyr M, Panagiotidis G, Sparve E, et al. (2009). Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones. Basic Clin Pharmacol Toxicol 105:339-344.
4. Ambadapadi S, Palii SP, James MO. (2011). Celecoxib modulation of estrogen sulfonation by SULT2A1 enzyme in vitro. American Association of Pharmaceutical Scientists Annual Meeting.Washington, DC: AAPS.
5. Anderson RJ, Kudlacek PE, Clemens DL. (1998). Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact 109:53-67. (Pubitemid 28161101)
6. Augustsson K, Skog K, Jagerstad M, et al. (1999). Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: A population-based study. Lancet 353:703-707. (Pubitemid 29103803)
7. Bamforth KJ, Dalgliesh K, Coughtrie MW. (1992). Inhibition of human liver steroid sulfotransferase activities by drugs: A novel mechanism of drug toxicity Eur J Pharmacol 228:15-21.
8. Bamforth KJ, Jones AL, Roberts RC, Coughtrie MW. (1993). Common food additives are potent inhibitors of human liver 17 alphaethinyloestradiol and dopamine sulphotransferases. Biochem Pharmacol 46:1713-1720. (Pubitemid 23349018)
9. Berger I, Guttman C, Amar D, et al. (2011). The molecular basis for the broad substrate specificity of human sulfotransferase 1A1. PLoS One 6:e26794.
10. Calafat AM, Ye X, Wong LY, et al. (2008). Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ Health Perspect 116:303-307. (Pubitemid 351395596)
11. Cer RZ, Mudunuri U, Stephens R, Lebeda FJ. (2009). IC50-to-Ki: A web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding. Nucleic Acids Res 37:W441-5.
12. Charbit AR, Akerman S, Goadsby PJ. (2010). Dopamine: What's new in migraine Curr Opin Neurol 23:275-281.
13. Chen G, Zhang D, Jing N, et al. (2003). Human gastrointestinal sulfotransferases: Identification and distribution. Toxicol Appl Pharmacol 187:186-197. (Pubitemid 36349350)
14. Claustre J, Serusclat P, Peyrin L. (1983). Glucuronide and sulfate catecholamine conjugates in rat and human plasma. J Neural Transm 56:265-278. (Pubitemid 13062303)
15. Comer KA, Falany CN. (1992). Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Mol Pharmacol 41:645-651. (Pubitemid 23021450)
16. Cornish-Bowden A. (2004). Fundamentals of enzyme kinetics. London: Portland Press.
17. Coughtrie MW, Johnston LE. (2001). Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug Metab Dispos 29:522-528. (Pubitemid 32275528)
18. Coughtrie MW, Sharp S, Maxwell K, Innes NP. (1998). Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact 109:3-27. (Pubitemid 28161098)
19. Crofton KM. (2008). Thyroid disrupting chemicals: Mechanisms and mixtures. Int J Androl 31:209-222. (Pubitemid 351341380)
20. Cui D, Booth-Genthe CL, Carlini E, et al. (2004). Heterotropic modulation of sulfotransferase 2A1 activity by celecoxib: Product ratio switching of ethynylestradiol sulfation. Drug Metab Dispos 32: 1260-1264. (Pubitemid 39410910)
21. Dajani R, Cleasby A, Neu M, et al. (1999). X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem 274:37862-37868. (Pubitemid 30026852)
22. Dajani R, Hood AM, Coughtrie MWH. (1998). A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol Pharmacol 54:942-948. (Pubitemid 29002035)
23. De Santi C, Pietrabissa A, Mosca F, et al. (2002). Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. Xenobiotica 32:363-368. (Pubitemid 34620942)
24. De Santi C, Pietrabissa A, Spisni R, et al. (2000). Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30:857-866.
25. Den Hond E, Paulussen M, Geens T, et al. (2013). Biomarkers of human exposure to personal care products: Results from the Flemish Environment and Health Study (FLEHS 2007-2011). Sci Total Environ 463-464C:102-110.
26. Djuric Z, Severson RK, Kato I. (2012). Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr Cancer 64:351-360.
27. Duanmu ZB, Weckle A, Koukouritaki SB, et al. (2006). Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre-and postnatal human liver. J Pharmacol Exp Ther 316: 1310-1317. (Pubitemid 43345307)
28. Eagle K. (2012a). SULT1A inhibition and how a migraine stops. Headache 52:1321.
29. Eagle K. (2012b). Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines. Food Chem Toxicol 50:2243-2249.
30. Eaton EA, Walle UK, Lewis AJ, et al. (1996). Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos 24: 232-237. (Pubitemid 26063910)
31. Eisenhofer G, Aneman A, Friberg P, et al. (1997). Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864-3871. (Pubitemid 27509384)
32. Ekuase EJ, Liu Y, Lehmler HJ, et al. (2011). Structure-activity relationships for hydroxylated polychlorinated biphenyls as inhibitors of the sulfation of dehydroepiandrosterone catalyzed by human hydroxysteroid sulfotransferase SULT2A1. Chem Res Toxicol 24: 1720-1728.
33. Falany CN. (1991). Molecular enzymology of human liver cytosolic sulfotransferases. Trends Pharmacol Sci 12:255-259.
34. Falany CN. (1997). Enzymology of human cytosolic sulfotransferases.FASEB J 11:206-216. (Pubitemid 27118321)
35. Furimsky AM, Green CE, Sharp LE, et al. (2008). Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1. Drug Metab Dispos 36: 129-136.
36. Gamage NU, Tsvetanov S, Duggleby RG, et al. (2005). The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates. J Biol Chem 280:41482-41486. (Pubitemid 41832208)
37. Gibb C, Glover V, Sandler M. (1987). In vitro inhibition of phenolsulphotransferase by food and drink constituents. Biochem Pharmacol 36:2325-2330. (Pubitemid 17097408)
38. Glatt H. (2002). Sulphotransferases. In: Ioannides C, ed. Enzyme Systems that Metabolise Drugs and Other Xenobiotics. Chichester: John Wiley & Sons, Ltd., 353-439.
39. Glatt H. (2005). Activation and inactivation of carcinogens and mutagens by human sulfotransferases. In: Pacifici GM, Coughtrie MWH, eds. Human Cytosolic Sulfotransferases. Boca Raton, Taylor and Francis.
40. Guvenius DM, Hassanzadeh P, Bergman A, Noren K. (2002).Metabolites of polychlorinated biphenyls in human liver and adipose tissue. Environ Toxicol Chem 21:2264-2269. (Pubitemid 35155118)
41. Hamers T, Kamstra JH, Sonneveld E, et al. (2006). In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.Toxicol Sci 92:157-173. (Pubitemid 43985800)
42. Harris RM, Hawker RJ, Langman MJ, et al. (1998). Inhibition of phenolsulphotransferase by salicylic acid: A possible mechanism by which aspirin may reduce carcinogenesis. Gut 42:272-275. (Pubitemid 28212184)
43. Harris RM, Kirk CJ, Waring RH. (2005). Non-genomic effects of endocrine disrupters: Inhibition of estrogen sulfotransferase by phenols and chlorinated phenols. Mol Cell Endocrinol 244:72-74. (Pubitemid 41628231)
44. Harris RM, Waring RH. (2008). Sulfotransferase inhibition: Potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. Curr Drug Metab 9:269-275. (Pubitemid 351836415)
45. Her C, Szumlanski C, Aksoy IA, Weinshilboum RM. (1996). Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: Immunochemical characterization of individual variation.Drug Metab Dispos 24:1328-1335.
46. Heroux JA, Falany CN, Roth JA. (1989). Immunological characterization of human phenol sulfotransferase. Mol Pharmacol 36:29-33. (Pubitemid 19191255)
47. Hoelzl C, Glatt H, Meinl W, et al. (2008). Consumption of Brussels sprouts protects peripheral human lymphocytes against 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) and oxidative DNAdamage: Results of a controlled human intervention trial. Mol Nutr Food Res 52:330-341.
48. Huang C, Chen Y, Zhou T, Chen G. (2009). Sulfation of dietary flavonoids by human sulfotransferases. Xenobiotica 39: 312-322.
49. James MO, Li W, Summerlot DP, et al. (2010). Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta.Environ Int 36:942-949.
50. Jones AL, Roberts RC, Colvin DW, et al. (1995). Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine. Eur J Clin Pharmacol 49:109-114.
51. Kester MH, Bulduk S, Tibboel D, et al. (2000). Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: A novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141:1897-1900. (Pubitemid 32274420)
52. Kester MH, Bulduk S, Van Toor H, et al. (2002). Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 87:1142-1150. (Pubitemid 36121079)
53. King RS, Ghosh AA, Wu J. (2006). Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents. Curr Drug Metab 7:745-753. (Pubitemid 44509680)
54. Ko K, Kurogi K, Davidson G, et al. (2012). Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases. J Biochem 152: 275-283.
55. Koal T, Schmiederer D, Pham-Tuan H, et al. (2012). Standardized LC-MS/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol 129:129-138.
56. Littlewood JT, Glover V, Sandler M. (1985). Red wine contains a potent inhibitor of phenolsulphotransferase. Br J Clin Pharmacol 19: 275-278. (Pubitemid 16216347)
57. Liu Y, Apak TI, Lehmler HJ, et al. (2006). Hydroxylated polychlorinated biphenyls are substrates and inhibitors of human hydroxysteroid sulfotransferase SULT2A1. Chem Res Toxicol 19:1420-1425. (Pubitemid 44863483)
58. Liu Y, Lehmler HJ, Robertson LW, Duffel MW. (2011). Physicochemical properties of hydroxylated polychlorinated biphenyls aid in predicting their interactions with rat sulfotransferase 1A1 (rSULT1A1). Chem Biol Interact 189:153-160.
59. Liu Y, Smart JT, Song Y, et al. (2009). Structure-activity relationships for hydroxylated polychlorinated biphenyls as substrates and inhibitors of rat sulfotransferases and modification of these relationships by changes in thiol status. Drug Metab Dispos 37:1065-1072.
60. Ma B, Shou M, Schrag ML. (2003). Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro. Drug Metab Dispos 31:1300-1305. (Pubitemid 37310316)
61. Marchetti F, De Santi C, Vietri M, et al. (2001). Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 31: 841-847. (Pubitemid 34074787)
62. Mesia-Vela S, Kauffman FC. (2003). Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica 33:1211-1220. (Pubitemid 38122243)
63. Miksits M, Maier-Salamon A, Aust S, et al. (2005). Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35: 1101-1119. (Pubitemid 43163249)
64. Miksits M, Wlcek K, Svoboda M, et al. (2010). Expression of sulfotransferases and sulfatases in human breast cancer: Impact on resveratrol metabolism. Cancer Lett 289:237-245.
65. Miners JO, Lillywhite KJ, Yoovathaworn K, et al. (1990).Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver-microsomes. Biochem Pharmacol 40:595-600. (Pubitemid 20241126)
66. Morimitsu Y, Sugihara N, Furuno K. (2004). Inhibitory effect of flavonoids on sulfo-and glucurono-conjugation of acetaminophen in rat cultured hepatocytes and liver subcellular preparations. Biol Pharm Bull 27:714-717. (Pubitemid 41694678)
67. Nagai M, Fukamachi T, Tsujimoto M, et al. (2009). Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol Pharm Bull 32:105-109.
68. Nagar S, Walther S, Blanchard RL. (2006). Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol Pharmacol 69:2084-2092. (Pubitemid 43894328)
69. Nishimuta H, Ohtani H, Tsujimoto M, et al. (2007). Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos 28:491-500. (Pubitemid 351200987)
70. Nishimuta H, Tsujimoto M, Ogura K, et al. (2005). Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3. Pharm Res 22: 1406-1410. (Pubitemid 41176045)
71. Ohkimoto K, Liu MY, Suiko M, et al. (2004). Characterization of a zebrafish estrogen-sulfating cytosolic sulfotransferase: Inhibitory effects and mechanism of action of phytoestrogens. Chem Biol Interact 147:1-7. (Pubitemid 38076845)
72. Otake Y, Nolan AL, Walle UK, Walle T. (2000). Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J Steroid Biochem Mol Biol 73: 265-270.
73. Pasqualini JR, Chetrite GS. (2005). Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93:221-236. (Pubitemid 40602495)
74. Rampling RP, Bonham Carter SM, Glover V, Sandler M. (1984). Platelet monoamine oxidase and phenolsulphotransferase M and P in cancer.Clin Chim Acta 139:303-312. (Pubitemid 14111449)
75. Ratge D, Knoll E, Wisser H. (1986). Plasma free and conjugated catecholamines in clinical disorders. Life Sci 39:557-564. (Pubitemid 16076233)
76. Rehse PH, Zhou M, Lin SX. (2002). Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate.Biochem J 364:165-171. (Pubitemid 34538959)
77. Reith D, Medlicott NJ, Kumara De Silva R, et al. (2009). Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation. Clin Exp Pharmacol Physiol 36:35-42.
78. Richard K, Hume R, Kaptein E, et al. (2001). Sulfation of thyroid hormone and dopamine during human development: Ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain.J Clin Endocrinol Metab 86:2734-2742. (Pubitemid 32545731)
79. Riches Z, Stanley EL, Bloomer JC, Coughtrie MW. (2009). Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: The SULT "pie". Drug Metab Dispos 37:2255-2261.
80. Rohn KJ, Cook IT, Leyh TS, et al. (2012). Potent inhibition of human sulfotransferase 1A1 by 17alpha-ethinylestradiol: Role of 30-phosphoadenosine 50-phosphosulfate binding and structural rearrangements in regulating inhibition and activity. Drug Metab Dispos 40:1588-1595.
81. Runge-Morris M, Kocarek TA, Falany CN. (2013). Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab Rev 45: 15-33.
82. Sandau CD, Ayotte P, Dewailly E, et al. (2000). Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian inuit. Environ Health Perspect 108:611-616. (Pubitemid 30657866)
83. Sandau CD, Ayotte P, Dewailly E, et al. (2002). Pentachlorophenol and hydroxylated polychlorinated biphenyl metabolites in umbilical cord plasma of neonates from coastal populations in Quebec. Environ Health Perspect 110:411-417. (Pubitemid 34308606)
84. Saruwatari A, Okamura S, Nakajima Y, et al. (2008). Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells.J Med Food 11:623-628.
85. Schrag ML, Cui DH, Rushmore TH, et al. (2004). Sulfotransferase 1E1 is a low K-M isoform mediating the 3-O-sulfation of ethinyl estradiol.Drug Metab Dispos 32:1299-1303. (Pubitemid 39410916)
86. Schuur AG, Bergman A, Brouwer A, Visser TJ. (1999). Effects of pentachlorophenol and hydroxylated polychlorinated biphenyls on thyroid hormone conjugation in a rat and a human hepatoma cell line.Toxicol in Vitro 13:417-425. (Pubitemid 29354226)
87. Schuur AG, Legger FF, Van Meeteren ME, et al. (1998a). In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol 11: 1075-1081. (Pubitemid 28447297)
88. Schuur AG, Van Leeuwen-Bol I, Jong WM, et al. (1998b). In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: Isozyme specificity and inhibition kinetics. Toxicol Sci 45:188-194. (Pubitemid 28516659)
89. Schwaninger AE, Meyer MR, Zapp J, Maurer HH. (2011). Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4- dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases. Toxicol Lett 202:120-128.
90. Senggunprai L, Yoshinari K, Yamazoe Y. (2009). Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases. Biochem J 422:455-462.
91. Shevtsov S, Petrotchenko EV, Pedersen LC, Negishi M. (2003). Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. Environ Health Perspect 111:884-888. (Pubitemid 36790381)
92. Stanley EL, Hume R, Coughtrie MW. (2005). Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol 240: 32-42. (Pubitemid 41133369)
93. Strott CA. (2002). Sulfonation and molecular action. Endocr Rev 23: 703-732. (Pubitemid 35203256)
94. Tanaka T, Kojima T, Kawamori T, et al. (1993). Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res 53:2775-2779. (Pubitemid 23180514)
95. Teubner W, Meinl W, Florian S, et al. (2007). Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404:207-215. (Pubitemid 46849592)
96. Thomae BA, Rifki OF, Theobald MA, et al. (2003). Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: Functional genetic polymorphism. J Neurochem 87:809-819. (Pubitemid 37444557)
97. Toms LM, Allmyr M, Mueller JF, et al. (2011). Triclosan in individual human milk samples from Australia. Chemosphere 85:1682-1686.
98. Ung D, Nagar S. (2009). Trans-resveratrol-mediated inhibition of betaoestradiol conjugation in MCF-7 cells stably expressing human sulfotransferases SULT1A1 or SULT1E1, and human liver microsomes.Xenobiotica 39:72-79.
99. Vietri M, De Santi C, Pietrabissa A, et al. (2000a). Fenamates and the potent inhibition of human liver phenol sulphotransferase.Xenobiotica 30:111-116. (Pubitemid 30125112)
100. Vietri M, De Santi C, Pietrabissa A, et al. (2000b). Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs.Eur J Clin Pharmacol 56:81-87. (Pubitemid 30317787)
101. Vietri M, Pietrabissa A, Mosca F, et al. (2001). Human adult and foetal liver sulphotransferases: Inhibition by mefenamic acid and salicylic acid. Xenobiotica 31:153-161. (Pubitemid 32635343)
102. Vietri M, Pietrabissa A, Spisni R, et al. (2000c). Differential inhibition of hepatic and duodenal sulfation of (-)-salbutamol and minoxidil by mefenamic acid. Eur J Clin Pharmacol 56:477-479.
103. Vietri M, Vaglini F, Pietrabissa A, et al. (2002). Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin.Xenobiotica 32:587-594.
104. Walle T, Eaton EA, Walle UK. (1995). Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase. Biochem Pharmacol 50:731-734.
105. Wang LQ, Falany CN, James MO. (2004). Triclosan as a substrate and inhibitor of 30-phosphoadenosine 50-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions. Drug Metab Dispos 32:1162-1169. (Pubitemid 39287591)
106. Wang LQ, James MO. (2005). Sulfotransferase 2A1 forms estradiol-17-sulfate and celecoxib switches the dominant product from estradiol-3-sulfate to estradiol-17-sulfate. J Steroid Biochem Mol Biol 96: 367-374. (Pubitemid 41384138)
107. Wang LQ, James MO. (2006). Inhibition of sulfotransferases by xenobiotics. Curr Drug Metab 7:83-104.
108. Wang LQ, Lehmler HJ, Robertson LW, et al. (2005). In vitro inhibition of human hepatic and cDNA-expressed sulfotransferase activity with 3-hydroxybenzo[a]pyrene by polychlorobiphenylols. Environ Health Perspect 113:680-687. (Pubitemid 40862178)
109. Wang LQ, Lehmler HJ, Robertson LW, James MO. (2006).Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate. Chem Biol Interact 159:235-246. (Pubitemid 43112434)
110. Waring RH, Ayers S, Gescher AJ, et al. (2008). Phytoestrogens and xenoestrogens: The contribution of diet and environment to endocrine disruption. J Steroid Biochem Mol Biol 108:213-220. (Pubitemid 351179639)
111. Whittemore RM, Pearce LB, Roth JA. (1985). Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Biochemistry 24:2477-2482. (Pubitemid 15015753)
112. Yalcin EB, Struzik SM, King RS. (2008). Allosteric modulation of SULT2A1 by celecoxib and nimesulide: Computational analyses.Drug Metab Lett 2:198-204.
113. Yasuda S, Idell S, Fu J, et al. (2007). Cigarette smoke toxicants as substrates and inhibitors for human cytosolic SULTs. Toxicol Appl Pharmacol 221:13-20. (Pubitemid 46702277)
114. Yasuda S, Suiko M, Liu MC. (2005). Oral contraceptives as substrates and inhibitors for human cytosolic SULTs. J Biochem 137:401-406. (Pubitemid 40628448)
115. Yeh CT, Yen GC. (2003). Effects of phenolic acids on human phenolsulfotransferases in relation to their antioxidant activity.J Agric Food Chem 51:1474-1479.
116. Young Jr WF, Laws Jr ER, Sharbrough FW, Weinshilboum RM. (1985).Human phenol sulfotransferase: Correlation of brain and platelet activities. J Neurochem 44:1131-1137. (Pubitemid 15105765)
117. Zhang H, Varlamova O, Vargas FM, et al. (1998). Sulfuryl transfer: The catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 273:10888-10892. (Pubitemid 28204925)